bullish
Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters
361 Views17 Sep 2020 16:25
JHBP (CY) Holdings Ltd also known as Genor Biopharma has filed for an IPO on the Hong Kong Stock Exchange to raise about HK$2.48bn (US$320m). The...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- M3 Inc: Intelligent Adaption to Covid-19 Should Sustain Medtech Earnings Growth Even Post-Pandemic24 Sep 2020
- GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits21 Sep 2020
- ZTO Express Secondary: Overvalued and More Expensive than Global Delivery Giants18 Sep 2020
- ZTO Secondary: Entire Industry Expanding Capacity While Facing Pricing Pressure Is Not a Good Thing16 Sep 2020
- Hygeia Healthcare IPO (Part II): Healthy Valuation17 Jun 2020
- Venus Medtech IPO: First Mover Advantage in Chinese TAVR Market to Support Growth12 Aug 2019
x